Product information

Current status:

Cancelled Post Market

Current status date:

2025-07-03

Original market date: ^{See footnote 1}

1996-10-17

Product name:

ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP

DIN:

01960865 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

5

Schedule(s):

ETHICAL

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.04.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:^{See footnote5}

0514462001